Beijing Foyou Pharma CO., LTD.

In 2022, Foyou Pharmaceutical achieved a significant milestone by successfully listing on the Main Board of the A-share market (Stock Code: 601089).​ Headquartered in Beijing, the company operates state-of-the-art R&D centers and advanced manufacturing bases. Our diverse product portfolio spans innovative drugs, generic chemicals, traditional Chinese medicines, health products, and medical devices. We are backed by three key subsidiaries: Winsunny Pharma, Front Pharma, and Zhejiang Asen-pharm. By integrating R&D, manufacturing, and marketing into a seamless ecosystem, Foyou Pharmaceutical has established a robust core competitive advantage.